FDA Signals Shift in Regulatory Approach to Autoimmune CAR-T Recent signals from the US FDA suggest regulators are preparing a more tailored approach for CAR-T therapies in autoimmune diseases. Read more
Rare Disease CRO Services | Cromos Pharma Introduction to Rare Disease CRO Support A rare disease is defined differently across regulatory regions. Rare diseases affect an estimated 30 million people in the EU (roughly 1 in 17, or 4% of the population) and over 30 million in the U.S. (1 in 10 Americans). These definitions enable incentives such as market exclusivity, tax credits, Read more
oncology cro
Oncology CRO: How to Choose the Right Partner for Complex Oncology Clinical Trials Oncology drug development is evolving rapidly as clinical trials become larger in number and more complex in design. The global oncology clinical trials market was valued at approximately $13.9 billion in 2025 and is expected to reach about $18.8 billion by 2031, reflecting steady growth alongside the increasing number and complexity of oncology studies.  As a result, selecting the right oncology Read more
World Kidney Day 2026 | What Sponsors Should Know About the Future of Kidney Trials | Cromos Pharma
World Kidney Day 2026 | What Sponsors Should Know About the Future of Kidney Trials As World Kidney Day 2026 is marked around the world, kidney disease is increasingly moving to the forefront of global healthcare discussions. Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us